TrialFind
Saved trials
Back to results
Completed
Phase 3
Long-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's Disease
NCT02079246
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
US027
Birmingham, Alabama, United States
+257 additional locations
View on ClinicalTrials.gov
Official details